114 related articles for article (PubMed ID: 17381179)
1. eHiTS-to-VMD interface application. The search for tyrosine-tRNA ligase inhibitors.
Eitner K; Gaweda T; Hoffmann M; Jura M; Rychlewski L; Barciszewski J
J Chem Inf Model; 2007; 47(2):695-702. PubMed ID: 17381179
[TBL] [Abstract][Full Text] [Related]
2. Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs.
Crivori P; Poggesi I
Eur J Med Chem; 2006 Jul; 41(7):795-808. PubMed ID: 16644065
[TBL] [Abstract][Full Text] [Related]
3. Analysis of a high-throughput screening data set using potency-scaled molecular similarity algorithms.
Vogt I; Bajorath J
J Chem Inf Model; 2007; 47(2):367-75. PubMed ID: 17300172
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of virtual screening as a tool for chemical genetic applications.
Campagna-Slater V; Schapira M
J Chem Inf Model; 2009 Sep; 49(9):2082-91. PubMed ID: 19702241
[TBL] [Abstract][Full Text] [Related]
5. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
Park H; Bhattarai BR; Ham SW; Cho H
Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
[TBL] [Abstract][Full Text] [Related]
6. Fast and efficient in silico 3D screening: toward maximum computational efficiency of pharmacophore-based and shape-based approaches.
Kirchmair J; Ristic S; Eder K; Markt P; Wolber G; Laggner C; Langer T
J Chem Inf Model; 2007; 47(6):2182-96. PubMed ID: 17929799
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent thermolysin inhibitors using structure based virtual screening and binding assays.
Khan MT; Fuskevåg OM; Sylte I
J Med Chem; 2009 Jan; 52(1):48-61. PubMed ID: 19072688
[TBL] [Abstract][Full Text] [Related]
8. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel cathepsin S inhibitors by pharmacophore-based virtual high-throughput screening.
Markt P; McGoohan C; Walker B; Kirchmair J; Feldmann C; De Martino G; Spitzer G; Distinto S; Schuster D; Wolber G; Laggner C; Langer T
J Chem Inf Model; 2008 Aug; 48(8):1693-705. PubMed ID: 18637674
[TBL] [Abstract][Full Text] [Related]
10. Pursuing aldose reductase inhibitors through in situ cross-docking and similarity-based virtual screening.
Cosconati S; Marinelli L; La Motta C; Sartini S; Da Settimo F; Olson AJ; Novellino E
J Med Chem; 2009 Sep; 52(18):5578-81. PubMed ID: 19719141
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore-based virtual screening: the discovery of novel methionyl-tRNA synthetase inhibitors.
Kim SY; Lee YS; Kang T; Kim S; Lee J
Bioorg Med Chem Lett; 2006 Sep; 16(18):4898-907. PubMed ID: 16824759
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin.
Jenkins JL; Kao RY; Shapiro R
Proteins; 2003 Jan; 50(1):81-93. PubMed ID: 12471601
[TBL] [Abstract][Full Text] [Related]
13. In silico chemical library screening and experimental validation of a novel 9-aminoacridine based lead-inhibitor of human S-adenosylmethionine decarboxylase.
Brooks WH; McCloskey DE; Daniel KG; Ealick SE; Secrist JA; Waud WR; Pegg AE; Guida WC
J Chem Inf Model; 2007; 47(5):1897-905. PubMed ID: 17676832
[TBL] [Abstract][Full Text] [Related]
14. Virtual high-throughput screening of molecular databases.
Seifert MH; Kraus J; Kramer B
Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
[TBL] [Abstract][Full Text] [Related]
15. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel inhibitors of methionyl-tRNA synthetase (MetRS) by virtual screening.
Finn J; Stidham M; Hilgers M; G C K
Bioorg Med Chem Lett; 2008 Jul; 18(14):3932-7. PubMed ID: 18590962
[TBL] [Abstract][Full Text] [Related]
17. Calculating the probability of detection for inhibitors in enzymatic or binding reactions in high-throughput screening.
Buxser S; Vroegop S
Anal Biochem; 2005 May; 340(1):1-13. PubMed ID: 15802124
[TBL] [Abstract][Full Text] [Related]
18. Scoring ligand similarity in structure-based virtual screening.
Zavodszky MI; Rohatgi A; Van Voorst JR; Yan H; Kuhn LA
J Mol Recognit; 2009; 22(4):280-92. PubMed ID: 19235177
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of bacterial tyrosyl tRNA synthetase: synthesis of carbocyclic analogues of the natural product SB-219383.
Jarvest RL; Berge JM; Houge-Frydrych CS; Mensah LM; O'Hanlon PJ; Pope AJ
Bioorg Med Chem Lett; 2001 Sep; 11(18):2499-502. PubMed ID: 11549455
[TBL] [Abstract][Full Text] [Related]
20. Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application.
Cozza G; Bonvini P; Zorzi E; Poletto G; Pagano MA; Sarno S; Donella-Deana A; Zagotto G; Rosolen A; Pinna LA; Meggio F; Moro S
J Med Chem; 2006 Apr; 49(8):2363-6. PubMed ID: 16610779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
